Cutting edge: Perforin down-regulates CD4 and CD8 T cell-mediated immune responses to a transplanted organ

Journal of Immunology

Volumn 170, Issue 4, 2003, Pages 1611-1614

  Bose, Anirban ^a   Inoue, Yoshihiko ^b   Kokko, Kenneth E ^c   Lakkis, Fadi G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; PERFORIN;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOREGULATION; KINETICS; KNOCKOUT MOUSE; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN ALLOGRAFT; SKIN TRANSPLANTATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TARGET CELL; TRANSPLANTATION TOLERANCE;

EID: 0037442189     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.4.1611     Document Type: Article

References (35)

1. Barry, M., and R. C. Bleackley. 2002. Cytotoxic T lymphocytes: all roads lead to death. Nat. Rev. Immunol. 2:401.
2. Kagi, D., B. Ledermann, K. Burki, R. M. Zinkernagel, and H. Hengartner. 1996. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14:207.
3. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
4. Walsh, C. M., M. Matloubian, C. C. Liu, R. Ueda, C. G. Kurahara, J. L. Christensen, M. T. Huang, J. D. Young, R. Ahmed, and W. R. Clark. 1994. Immune function in mice lacking the perforin genes. Proc. Natl. Acad. Sci. USA 91:10854.
5. van den Broek, M. E., D. Kagi, F. Ossendorp, R. Toes, S. Vamvakas, W. K. Lutz, C. J. Melief, R. M. Zinkernagel, and H. Hengartner. 1996. Decreased tumor surveillance in perforin-deficient mice. J. Exp. Med. 184:1781.
6. Sprent, J., M. Schaefer, D. Lo, and R. Korngold. 1986. Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 difference. J. Exp. Med. 163:998.
7. + T cells. Transplantation 41:634.
8. Pascoe, M. D., S. E. Marshall, K. I. Welsh, L. M. Fulton, and D. A. Hughes. 2000. Increased accuracy of renal allograft rejection diagnosis using combined perforin, granzyme B, and Fas ligand fine-needle aspiration immunocytology. Transplantation 69:2547.
9. Li, B., C. Hartono, R. Ding, V. K. Sharma, R. Ramaswamy, B. Qian, D. Serur, J. Mouradian, J. E. Schwartz, and M. Suthanthiran. 2001. Noninvasive diagnosis of renal allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N. Engl. J. Med. 344:947.
10. Legros-Maida, S., A. Soulie, C. Benvenuti, A. Wargnier, N. Vallee, C. Berthou, J. Guillet, M. Sasportes, and N. Sigaux. 1994. Granzyme B and perforin can be used as predictive markers of acute rejection in heart transplantation. Eur. J. Immunol. 24:229.
11. Schultz, M., H. J. Schuurman, J. Joergensen, C. Steiner, T. Meerloo, D. Kagi, H. Hengartner, R. M. Zinkernagel, M. H. Schreier, K. Burki, and B. Ledermann. 1995. Acute rejection of vascular heart allografts by perforin-deficient mice. Eur. J. Immunol. 25:474.
12. Selvaggi, G., C. Ricordi, E. R. Podack, and L. Inverardi. 1996. The role of the perforin and Fas pathways of cytotoxicity in skin graft rejection. Transplantation 62:1912.
13. Ahmed, K. R., T. B. Guo, and K. K. Gaal. 1997. Islet rejection in perforin-deficient mice: the role of perforin and Fas. Transplantation 63:951.
14. Kagi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528.
15. + cytotoxic T lymphocytemediated lysis. J. Immunol. 150:4303
16. Kaspar, A. A., S. Okada, J. Kumar, F. R. Poulain, K. A. Drouvalakis, A. Kelekar, D. A. Hanson, R. M. Kluck, Y. Hitoshi, D. E. Johnson, et al. 2001. A distinct pathway of cell-mediated apoptosis initiated by granulysin. J. Immunol. 167:350.
17. Arakelov, A., and F. G. Lakkis. 2000. The alloimmune response and effector mechanisms of allograft rejection. Semin. Nephrol. 20:95.
18. de Saint Basile, G., and A. Fischer. 2001. The role of cytotoxicity in lymphocyte homeostasis. Curr. Opin. Immunol. 13:549.
19. + T cell response to infection. Curr. Opin. Immunol. 14:360.
20. Stepp, S. E., R. Dufourcq-Lagelouse, F. Le Deist, S. Bhawan, S. Certain, P. A. Mathew, J.-I. Henter, M. Bennett, A. Fischer, G. de Saint Basile, and V. Kumar. 1999. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 286:1957.
21. + T cell homeostasis by perforin and interferon-γ. Science 290:1354.
22. Matloubian, M., M. Suresh, A. Glass, M. Galvan, K. Chow, J. K. Whitmire, C. M. Walsh, W. R. Clark, and R. Ahmed. 1999. A role for perforin in downregulating T-cell responses during chronic viral infection. J. Virol. 73:2527.
23. Spaner, D., K. Raju, B. Rabinovich, and R. G. Miller. 1999. A role for perforin in activation-induced T cell death in vivo: increased expansion of allogeneic perforindeficient T cells in SCID mice. J. Immunol. 162:1192.
24. Shustov, A., I. Luzina, P. Nguyen, J. C. Papadimitriou, B. Handwerger, K. B. Elkon, and C. S. Via. 2000. Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity. J. Clin. Invest. 106:R39.
25. Peng, S. L., J. Moslehi, M. E. Robert, and J. Craft. 1998. Perforin protects against autoimmunity in lupus-prone mice. J. Immunol. 160:652.
26. Spaner, D., K. Raju, L. Radvanyi, Y. Lin, and R. G. Miller. 1998. A role for perforin in activation-induced cell death. J. Immunol. 160:2655.
27. Spielman, J., R. K. Lee, and E. R. Podack. 1998. Perforin/Fas-ligand double deficiency is associated with macrophage expansion and severe pancreatitis. J. Immunol. 161:7063.
28. + T cells: in vivo priming and antigen-specific immunity against Listeria monocytogenes. J. Immunol. 162:980.
29. + T cells in vivo: implications for adaptive immunotherapy. Eur. J. Immunol. 31:1772.
30. Rosenberg, A. S. 1992. Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. Annu. Rev. Immunol. 10:333.
31. Dai, Z., B. T. Konieczny, F. K. Baddoura, and F. G. Lakkis. 1998. Impaired alloantigen-mediated T cell apoptosis and failure to induce long term allograft survival in interleukin-2-deficient mice. J. Immunol. 161:1659.
32. Li, Y., X. C. Li, X. X. Zheng, A. D. Wells, L. A. Turka, and T. B. Strom. 1999. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral tolerance. Nat. Med. 5:1298.
33. Dai, Z., and F. G. Lakkis. 1999. The role ofcytokines, CTLA-4, and costimulation in transplant tolerance and rejection. Curr. Opin. Immunol. 11:504.
34. + T cells by perforin. Eur. J. Immunol. 29:3262.
35. + CTL ex vivo. J. Immunol. 168:5954.